Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
30852663
Public Release Type:
Journal
Publication Year: 2020
Affiliation: Nephrology Division, Department of Medicine and Pediatrics, New York University Langone Health and New York University School of Medicine, New York, NY, USA. lada.bearalasic@nyumc.org.; Rare Kidney Stone Consortium, Rochester, USA.; Rare Kidney Stone Consortium, Rochester, USA.; Rare Kidney Stone Consortium, Rochester, USA.; Rare Kidney Stone Consortium, Rochester, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman, School of Medicine, Philadelphia, PA, USA.; Nephrology Division, Department of Medicine and Pediatrics, New York University Langone Health and New York University School of Medicine, New York, NY, USA.; Geisinger Commonwealth School of Medicine, Scranton, PA, USA.; Rare Kidney Stone Consortium, Rochester, USA.; Nephrology Division, Department of Medicine and Pediatrics, New York University Langone Health and New York University School of Medicine, New York, NY, USA.; Rare Kidney Stone Consortium, Rochester, USA.; Rare Kidney Stone Consortium, Rochester, USA.
DOI:
https://doi.org/10.1007/s00467-019-04210-0
Authors:
Beara-Lasic Lada, Cogal Andrea, Mara Kristin, Enders Felicity, Mehta Ramila A, Haskic Zejfa, Furth Susan L, Trachtman Howard, Scheinman Steven J, Milliner Dawn S, Goldfarb David S, Harris Peter C, Lieske John C
Request IDs:
21203
Studies:
Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial
Dent disease type 1 (DD1) is a rare X-linked disorder caused mainly by CLCN5 mutations. Patients may present with nephrotic-range proteinuria leading to erroneous diagnosis of focal segmental glomerulosclerosis (FSGS) and unnecessary immunosuppressive treatments.
